NT: Faith and Trust in management are not an appropriate response to the CEO not addressing Lympro's abrupt drop in expected revenues 4 weeks before it's launch.
Jason has raised a RED FLAG regarding Lympro and Gerald needs to address it today!!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links